Evidence map›Paper›PMID 17942534›Full record

ArticleJournal of virology2008

WFDC1/ps20 is a novel innate immunomodulatory signature protein of human immunodeficiency virus (HIV)-permissive CD4+ CD45RO+ memory T cells that promotes infection by upregulating CD54 integrin expression and is elevated in HIV type 1 infection.

R Alvarez, J Reading, D F L King, M Hayes, P Easterbrook, F Farzaneh, S Ressler, F Yang, D Rowley, A Vyakarnam

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Increased Platelet-CD4Frontiers in immunology · 2021
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. The mouth: a gateway or a trap for HIV?AIDS (London, England) · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

R AlvarezDepartment of Infectious Diseases, King's College London, 2nd Floor New Guy's House, Guy's Campus, London SE1 9NU, United Kingdom.
J Reading
D F L King
M Hayes
P Easterbrook
F Farzaneh
S Ressler
F Yang
D Rowley
A Vyakarnam
King's College London · GBBaylor College of Medicine · US

Funding

MESENCHYMAL DERIVED GROWTH FACTORS IN PROSTATIC CANCERR01CA058093 · NCI · BAYLOR COLLEGE OF MEDICINE · PI ROWLEY, DAVID R · 1992 to 2013
$3.3M
STROMAL GROWTH FACTORS IN BENIGN PROSTATIC HYPERPLASIAR01DK045909 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI ROWLEY, DAVID R · 1992 to 2003
$1.0M
Biotechnology and Biological Sciences Research Council BB/E005896/1Medical Research Council G0200585NCI NIH HHS R01 CA058093NCI NIH HHS R01CA58093NIDDK NIH HHS R01 DK045909NIDDK NIH HHS R01DK45909
6 · The paper itself

Abstract

Understanding why human immunodeficiency virus (HIV) preferentially infects some CD4(+) CD45RO(+) memory T cells has implications for antiviral immunity and pathogenesis. We report that differential expression of a novel secreted factor, ps20, previously implicated in tissue remodeling, may underlie why some CD4 T cells are preferentially targeted. We show that (i) there is a significant positive correlation between endogenous ps20 mRNA in diverse CD4 T-cell populations and in vitro infection, (ii) a ps20(+) permissive cell can be made less permissive by antibody blockade- or small-interference RNA-mediated knockdown of endogenous ps20, and (iii) conversely, a ps20(low) cell can be more permissive by adding ps20 exogenously or engineering stable ps20 expression by retroviral transduction. ps20 expression is normally detectable in CD4 T cells after in vitro activation and interleukin-2 expansion, and such oligoclonal populations comprise ps20(positive) and ps20(low/negative) isogenic clones at an early differentiation stage (CD45RO(+)/CD25(+)/CD28(+)/CD57(-)). This pattern is altered in chronic HIV infection, where ex vivo CD4(+) CD45RO(+) T cells express elevated ps20. ps20 promoted HIV entry via fusion and augmented CD54 integrin expression; both of these effects were reversed by anti-ps20 antibody. We therefore propose ps20 to be a novel signature of HIV-permissive CD4 T cells that promotes infection in an autocrine and paracrine manner and that HIV has coopted a fundamental role of ps20 in promoting cell adhesion for its benefit. Disrupting the ps20 pathway may therefore provide a novel anti-HIV strategy.

Indexed as

CD4-Positive T-LymphocytesCell LineCells, CulturedGene SilencingHIV-1HumansIntercellular Adhesion Molecule-1ProteinsT-Lymphocyte SubsetsIntercellular Adhesion Molecule-1ProteinsWFDC1 protein, human

Identifiers

PMID17942534
PMCPMC2224370
OpenAlexW2161847980

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.